Drugs Begining With“p”
Investigated for use/treatment in hyperuricemia.
For treatment of adenosine deaminase deficiency
For the treatment of neovascular (wet) age-related macular degeneration.
For treatment of acute lymphoblastic leukemia
Increases leukocyte production, for treatment in non-myeloid cancer, neutropenia and bone marrow transplant
Peginesatide is used for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis
For treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcoma.
For the treatment of chronic hepatitis C in patients not previously treated with interferon alpha who have compensated liver disease and are at least 18 years of age.
For the treatment of patients with relapsing forms of multiple sclerosis.
For the treatment of chronic gout in adult patients refractory to conventional therapy.
Pegvisomant is a growth hormone receptor antagonist used for the treatment of acromegaly.
For the treatment of patients with unresectable or metastatic melanoma and disease progression following therapy with ipilimumab and, if BRAF V600 mutation positive, a BRAF inhibitor. It is also for the treatment of patients with metastatic NSCLC (non-small cell lung cancer) whose tumors express PD-L1 (as determined by an approved test) and who have disease progression on or after platinum-containing chemotherapy.
Used in combination with cisplatin for the treatment of malignant pleural mesothelioma in adults whose disease is unresectable or who otherwise are not candidates for potentially curative surgery. Also used as a monotherapy for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) after prior chemotherapy
For the prevention of itching of the eyes caused by allergies such as hay fever, and allergic conjunctivitis